New shorter radiation regimen could cut cervical cancer treatment time in half

NCT ID NCT07439497

Recruiting now Disease control Sponsor: Samsung Medical Center Source: ClinicalTrials.gov ↗

First seen Feb 28, 2026 · Last updated Jun 19, 2026 · Updated 19 times

Summary

This study tests a shorter, more intense radiation schedule combined with chemotherapy for cervical cancer. Standard treatment takes 7-8 weeks, but this approach aims to finish in less time while still controlling the tumor. The trial includes 34 adults with advanced cervical cancer (stage IIB-IVA) who are healthy enough for treatment. Researchers will measure tumor shrinkage and track cancer return and side effects over 3 years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Samsung Medical Center
RECRUITING

Seoul, Gangnam-gu, 06351, South Korea

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

cervical cancer Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER